Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07065721 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

A NA study of Type 2 Diabetes Mellitus (T2DM), sponsored by San Diego State University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07065721 is a NA study of Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 40 participants, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07065721, a NA study of Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by San Diego State University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.

Interventions

  • DEVICE Continuous glucose monitor

Study Locations (1)

California

  • Scripps Health - San Diego

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-10-02
Est. Completion 2026-07-30
Phase NA

Sponsor

San Diego State University

118 total trials

What the Registry Record Tells You About NCT07065721

The ClinicalTrials.gov registry entry for NCT07065721 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower). The listed sponsor is San Diego State University, which has 118 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor is the first listed.

NCT07065721 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07065721 about?

NCT07065721 is a clinical study titled "Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults". Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitator...

What is the current status of trial NCT07065721?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-10-02. Estimated completion is 2026-07-30.

What conditions does trial NCT07065721 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM).

What interventions are being tested in trial NCT07065721?

The interventions under investigation include: Continuous glucose monitor (DEVICE).

Who is sponsoring clinical trial NCT07065721?

This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07065721 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus (T2DM)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.